scPharmaceuticals Inc. (SCPH)
SCPH$118.27B
Large CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBURLINGTON
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SCPH News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
ceftriaxone
Pharmacokinetics in Healthy Adults
Fursemide Injection Solution for subcutaneous administration (80 mg)
Heart Failure
Furosemide injection solution for subcutaneous administration (80 mg)
Heart Failure
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ceftriaxone | Phase 3 | Pharmacokinetics in Healthy Adults | - | - |
Fursemide Injection Solution for subcutaneous administration (80 mg) | Phase 3 | Heart Failure | - | - |
Furosemide injection solution for subcutaneous administration (80 mg) | Phase 2 | Heart Failure | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply